- Posted by Samir Gondalia
- On January 6, 2021
My guest today in this episode is Brian Hagopian who’s known as or at least I call him “the Kevin Bacon of the Boston life sciences industry”, either you know him or you know someone who knows him. He is currently the President of Clear Water Consulting, Inc.,and received his chemistry degree from Colgate University. […]
Read More
- Posted by Samir Gondalia
- On December 14, 2020
My guest today is Dr. Andrea Adamo who is the Founder and CEO of Zaiput Flow Technologies. He also serves as the Innovation Advisor at Snapdragon Chemistry. Dr. Adamo holds a Master of Science in Engineering from the University of Palermo, Italy and a Ph.D. in Fluid Mechanics from the University Federico II of Naples, […]
Read More
- Posted by Samir Gondalia
- On July 14, 2020
My guest today is Dr. Arindam Bose. Arindam is currently an Independent Consultant in biologics process development and manufacturing following a 35-year career in bioprocess development, clinical supply manufacturing, external partnering, corporate biotechnology strategy and advocacy for science-based regulations for biologics at Pfizer Worldwide R&D from where he retired as a Vice President. He served […]
Read More
- Posted by Samir Gondalia
- On June 9, 2020
My guest today is Prof Charles Cooney. Prof Cooney received his B.S. in chemical engineering from the University of Pennsylvania in 1966, and the S.M. (1967) and Ph.D. (1970) in biochemical engineering from MIT. He joined the MIT faculty as an assistant professor in 1970, becoming full professor in 1982. Prof Cooney’s honors include the […]
Read More
- Posted by Samir Gondalia
- On April 8, 2020
My guest today is David Sullivan, Sr. Director and Global Lead of Vaccines and Biologics MSAT at Pfizer. He did his Bachelor’s in Biotechnology from Worcester Polytechnic Institute and Master’s in Engineering Management from Tufts University. Over the years, he’s worked in process development, pilot plant, next generation technology, vaccines and biologocs MSAT. I have […]
Read More
- Posted by Samir Gondalia
- On March 30, 2020
Episode 7 – Salvatore Mascia and Continuous Manufacturing My guest today is Salvatore Mascia. Sal is the Co-Founder & CEO of CONTINUUS Pharmaceuticals based in Woburn, MA. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end continuous manufacturing process for pharmaceuticals. […]
Read More
- Posted by Samir Gondalia
- On March 3, 2020
Episode 6 – Matt Roberge and the Global Pharma Forces My guest today is Matt Roberge. He got his Mechanical engineering degree from Villanova Uni. He currently works for Pfizer and serves as a senior director of Global technology network and Emerging market. He has a truly global organization with teams in the USA, China, […]
Read More
- Posted by Samir Gondalia
- On June 4, 2019
Episode 5 – Blockchain and Fake Drugs with Dr. Hariawala, Prof Vaishnav and Mr. Mankodi Dr. Mukesh Hariawala is a world-renowned heart surgeon, a highly sought after keynote speaker and Chairman of American Healthcare International (AHI). Prof Chintan Vaishnav is a professor at Sloan School of Management at MIT and Director of MIT Tata Center […]
Read More
- Posted by Samir Gondalia
- On March 11, 2019
Episode 4 – Continuous Manufacturing and Rare Events with Prof Bernhardt Trout (Image Source: https://cheme.mit.edu/profile/bernhardt-l-trout) Professor Trout directs the Molecular Engineering Laboratory and Novartis-MIT Center for Continuous Manufacturing at Massachusetts Institute of Technology, Cambridge, MA. He is considered one of the pioneers to pave the way for the continuous manufacturing in the highly complex and […]
Read More
- Posted by Samir Gondalia
- On January 8, 2019
Episode 3 – ISPE Boston and Individualized Medicine with Jack Campion Jack Campion is Principal at the Hart Companies. He is the immediate past president of the ISPE Boston area chapter. Jack and the show host Samir have known and worked with each other for many years in their capacity as the ISPE Boston board […]
Read More